Aptys pharma
The formulation company
The formulation company
Aptys Pharma is a CRDO (contract research and development organization) known for its expertise in pharmaceutical technologies and peptide delivery. Established in 2002 in France, the company specializes in offering ISO9001 aligned contract services in line with cGMP standards. Its offerings include custom-made formulation development encompassing in vivo/in vitro assessments, semi-solid dosage forms for topical and transdermal delivery, injectable peptide depot formulations, analytical development and validations, as well as quality control and ICH stability. The latest venture round investment received by Aptys Pharma was on 02 March 2009 from Sofimac Investment Managers. As a prominent player in the biotechnology and pharmaceutical industries, Aptys Pharma continues to advance its innovative products, positioning itself as a key player in the formulation and development sphere.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 1 |
|
02 Mar 2009 |
No recent news or press coverage available for Aptys pharma.
We care about your data, and we'd love to use cookies make your experience better.
